RAPID AND ROBUST EARLY ADME SOLUTIONS

RAPID AND ROBUST EARLY ADME SOLUTIONS
1 / 16 PagesView full catalog

RAPID AND ROBUST EARLY ADME SOLUTIONS

Product catalog summary
Introduction
The document outlines the challenges and solutions in conducting efficient ADME (Absorption, Distribution, Metabolism, and Excretion) studies during drug discovery. It emphasizes the importance of early ADME data to mitigate risks and improve the success rate of drug candidates by focusing on compounds with better safety profiles.
Risk Mitigation Through Early ADME Studies
Early ADME studies are essential for identifying compounds with toxic liabilities early in the drug discovery process. This approach reduces late-stage attrition and focuses resources on promising candidates. The document stresses the need for robust metabolite profiling and characterization according to Metabolites in Safety Testing (MIST) guidelines.
Agilent Early ADME Solutions
Agilent provides high-performance analytical instruments and automated workflows to facilitate early ADME studies. These tools include high-throughput assays and automated liquid handling systems that efficiently obtain necessary data for drug development.
Faster Data Acquisition
The Agilent RapidFire/MS system accelerates ADME workflows by eliminating the liquid chromatography step, allowing rapid analysis of samples. This system processes each sample in 6-10 seconds, significantly reducing data acquisition time.
Unparalleled Throughput with RapidFire/MS
The RapidFire/MS platform offers unmatched throughput, enabling quick analysis of large numbers of compounds. It supports various ADME assays, including CYP inhibition/induction and plasma protein binding assays, with results delivered within three days.
Greater Versatility and Performance
The RapidFire/MS system is versatile, supporting a wide range of compounds and integrating with various Agilent instruments for both qualitative and quantitative data collection. It maintains high data quality, correlating well with traditional LC/MS data.
Simultaneous Qualitative and Quantitative Measurements
Agilent's 6500 Series Q-TOF LC/MS instruments provide high sensitivity and mass accuracy, enabling simultaneous qualitative and quantitative data collection, accelerating decision-making processes in drug development.
NMR Analysis for Detailed Structure Elucidation
NMR is highlighted as a critical tool for structure verification and identification of drug metabolites. Agilent offers advanced NMR systems and software for detailed structure analysis, supporting both qualitative and quantitative studies.
Conclusion
Agilent's comprehensive suite of tools and technologies for early ADME studies enhances the efficiency and effectiveness of pharmaceutical research and development, enabling faster and more informed decision-making in drug discovery.
Specifications and Features
Agilent's Adaptive NMR and experimental strategies facilitate mixture analysis and solvent suppression. Selective excitation experiments and variable temperature experiments can be automated. Quantitative NMR (qNMR) tools in VnmrJ 3 software offer precise quantitation with an R2 value of 0.9995. Agilent cold probes enhance signal-to-noise ratios, enabling efficient data collection with minimal sample quantities.
Purification Systems
The Agilent 1260 Infinity Series LC, coupled with a mass spectrometer, provides high recovery and purity for drug metabolite purification. Fraction collection can be triggered by mass, refractive index, UV signal, or retention time, ensuring precise and confident sample collection. Agilent's fraction delay sensing (FDS) technology minimizes peak dispersion and cross-over between fractions.
Automation and Reproducibility
Agilent offers automation solutions for ADME assays, including liquid and microplate handling, robotic arms, and enclosed workstations. The Bravo Automated Liquid Handling Platform supports various ADME assays with customizable configurations. Agilent's automation tools integrate seamlessly with other instruments, enhancing throughput and reproducibility.
Sample Preparation and Chromatography
Agilent provides Bond Elut kits for solid phase extraction, offering a wide range of bonded silica and polymeric phases. Poroshell 120 columns and ZORBAX Rapid Resolution High Definition (RRHD) columns offer high-speed, high-resolution separations.
Service and Support
Agilent offers a 10-year value guarantee on instruments, ensuring reliable purchase and investment protection.
Conclusion
Agilent Technologies provides comprehensive solutions for ADME analysis, from sample preparation to purification and identification, supporting efficient and confident drug discovery decisions.
See more

Catalog excerpts

RAPID AND ROBUST EARLY ADME SOLUTIONS-1

RAPID AND ROBUST EARLY AD ME SOLUTI FOR PHARMACEUTICAL RESEARCH AND DEVELOPMENT

 Open the catalog to page 1
RAPID AND ROBUST EARLY ADME SOLUTIONS-2

AGILENT EARLY ADME SOLUTIONS REALIZE EFFECTIVE PHARMACEUTICALS Risk Mitigation Through Early ADME Studies The discovery and development of novel therapeutics is highly complex, with companies constantly adjusting the balance between efcacy, safety, speed, and cost. Rising regulatory pressures and increasing efforts to reduce costly late-stage attrition puts a greater emphasis on obtaining robust ADME data as early as possible for drug candidates.1 By eliminating compounds with toxic liabilities during discovery, instead of during clinical development, more resources can be focused on compounds...

 Open the catalog to page 2
RAPID AND ROBUST EARLY ADME SOLUTIONS-3

Analyses of samples from in vivo ADME studies, including bile, urine, feces, and plasma In vitro ADME assays, including metabolic stability, CYP inhibition/induction, permeability, and PgP inhibition High-throughput ADME assays Qualitative and quantitative ADME analyses Drug metabolite characterization, quantitation, and mixture analysis Metabolite purication Drug metabolite characterization Agilent Solutions ADME Workow ADME Applications Condently increase your odds of success with Agilent— Solutions for early ADME studies Agilent RapidFire/MS System p. 4 Agilent Bravo Automated Liquid Handling...

 Open the catalog to page 3
RAPID AND ROBUST EARLY ADME SOLUTIONS-4

ACCELERATE ANALYSIS Unparalleled Throughput with RapidFire/MS Quickly advancing the safest drug candidates involves making go/no-go decisions on a large number of compounds based on early ADME data. This requires performing ADME studies on very large numbers of compounds in the discovery setting at the throughputs necessary to provide data quickly, without compromising on the quality of the information generated. The Agilent RapidFire/MS platform provides the unmatched throughput at the plate-reader speeds required to do just that. Each sample is processed in 6–10 seconds and a single 384-well...

 Open the catalog to page 4
RAPID AND ROBUST EARLY ADME SOLUTIONS-5

Greater versatility For highly exible ADME studies, the RapidFire system is optimized for integration with Agilent Triple Quadrupole MS, TOF/MS, and Q-TOF/MS instruments. With TOF or Q-TOF/MS, quantitative data can be obtained in the same experiment that provides qualitative identication of the major metabolites, further increasing efciency (see p. 6). Figure 4. Data from eight different CYP enzyme/substrate pairs using traditional LC/MS and RapidFire/MS technology. The dotted line represents a line of unity.5 (See Agilent application note 5990-9184EN.) CLint RapidFire/MS (μL/min/mg) Uncompromising...

 Open the catalog to page 5
RAPID AND ROBUST EARLY ADME SOLUTIONS-6

STREAMLINE WORKFLOWS Simultaneous Qualitative and Quantitative Measurements As the pressure to increase productivity continues to challenge the pharmaceutical industry, ADME scientists have been looking for ways to conduct experiments faster and more efciently. The Agilent 6500 series of Q-TOF LC/MS instruments offers the sensitivity, mass accuracy, and resolution required to enable simultaneous qualitative and quantitative data collection, greatly increasing efciency (Figure 6). High sensitivity and mass accuracy for increased productivity While Agilent’s 6400 Series Triple Quadrupole instruments...

 Open the catalog to page 6
RAPID AND ROBUST EARLY ADME SOLUTIONS-7

MS/MS spectrum Figure 8. MS and MS/MS spectra of a buspirone monohydroxy metabolite from a 10-minute incubation sample (A). The sub-ppm mass accuracy of the precursor and fragment ions, along with the excellent isotopic fidelity (overall score > 99 %), provided high-confidence metabolite identification and structure elucidation Excellent separation and broad metabolite coverage was achieved in three and a half minutes (B). (See Agilent To achieve more efficient data acquisition, the Agilent 6550 Q-TOF provides a number of features that simplify and streamline experimental setup. With Q-TOF technology,...

 Open the catalog to page 7
RAPID AND ROBUST EARLY ADME SOLUTIONS-8

MAXIMIZE UNDERSTANDING NMR Analysis for Detailed Structure Elucidation NMR is the gold-standard, unmatched analytical technique for structure verication and identication of partial or complete unknowns. Thus, it is the method of choice for determining structures of metabolites directly from biological matrices or, more routinely, following purication. Agilent offers a wide range of NMR systems for the in-depth structure analysis of candidate compounds and their metabolites, including high-eld NMR systems, advanced probe technologies, automated sample loading, and our powerful VnmrJ 3 software...

 Open the catalog to page 8
RAPID AND ROBUST EARLY ADME SOLUTIONS-9

Figure 10. Agilent cold probes deliver data with higher signal-to-noise using limited sample in less time. This HSQC spectrum, collected on a 10 µg sample of retrorsine, represents routine analysis with a 600 MHz 3mm MicroSample Cold Probe. Sophisticated experiments, easy implementation The sample-centric design of VnmrJ 3 software makes it easy to set up experiments, collect data, and analyze results. With a large variety of built-in pulse sequences and experimental protocols, all organized for convenient setup and use, sophisticated experiments are easy to implement. While used most often for...

 Open the catalog to page 9
RAPID AND ROBUST EARLY ADME SOLUTIONS-10

SIMPLIFY PURIFICATION Achieve the Highest Recovery and Purity High recovery rates and purity levels are key issues for the isolation and purication of valuable drug metabolites. Agilent offers robust preparative LC solutions for the purication of nanogram to gram sample quantities. The Agilent 1260 Innity Series Analytical-scale Purication System (Figure 12) handles ow rates from 100 μL/min to 10 mL/min at pressures up to 600 bar, making it the system of choice for metabolite purication in the nanogram to low milligram range, on columns with internal diameters between 2.1 and 9.4 mm. Additionally,...

 Open the catalog to page 10
RAPID AND ROBUST EARLY ADME SOLUTIONS-11

Agilent fraction collector Conventional o t fraction collector action collec Fraction trigger from detector Lost proportion of fraction Spoilt proportion of fraction Delay volume (peak dispersion) Figure 13. Agilent fraction collectors are designed to have the lowest delay volumes to avoid peak dispersion and carry-over between fractions, ensuring the highest recovery and purity for your fractions, especially at low ow rates. (See Agilent publication 5990-8840EN) Inject Delay Calibration Sample (no column) mAU 1400 1000 600 200 Diverter Valve Fraction Delay Sensor Mass-triggered metabolite purication...

 Open the catalog to page 11

All Agilent Technologies - Life Sciences and Chemical catalogs and technical brochures

  1. MS500

    12  Pages

  2. 4200 MP-AES

    12  Pages

  3. Agilent B1507A

    22  Pages

  4. Agilent M9703A

    16  Pages

  5. I/O Hardware

    16  Pages

  6. VEE 9.32

    24  Pages

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.